Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $1.9m contract to Science Applications International Corporation (SAIC) to provide preclinical services for the development of biopharmaceutical products for infectious diseases.
Subscribe to our email newsletter
As per the contract, SAIC will provide product development services either directly or through management of subcontractors in areas including assay development, cGMP manufacture, feasibility assessments, process development, and regulatory activities.
SAIC senior vice president and business unit general manager Steve Comber said the company is pleased to assist and support NIAID with the development of biopharmaceutical products that will help prevent harmful diseases and improve human health.
The total funding could be up to $102m over the ten year period of performance, subject to availability of annual appropriations.